Eone Diagnomics Genome Stock Shares Owned By Insiders
| 245620 Stock | 415.00 17.00 3.94% |
Eone Diagnomics Genome fundamentals help investors to digest information that contributes to Eone Diagnomics' financial success or failures. It also enables traders to predict the movement of Eone Stock. The fundamental analysis module provides a way to measure Eone Diagnomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eone Diagnomics stock.
Eone |
Eone Diagnomics Genome Company Shares Owned By Insiders Analysis
Eone Diagnomics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Eone Diagnomics Shares Owned By Insiders | 30.90 % |
Most of Eone Diagnomics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eone Diagnomics Genome is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 30.9% of Eone Diagnomics Genome are shares owned by insiders. This is much higher than that of the sector and significantly higher than that of the Pharmaceuticals industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.
Eone Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eone Diagnomics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eone Diagnomics could also be used in its relative valuation, which is a method of valuing Eone Diagnomics by comparing valuation metrics of similar companies.Eone Diagnomics is currently under evaluation in shares owned by insiders category among related companies.
Eone Fundamentals
| Return On Equity | -68.42 | |||
| Return On Asset | -0.0194 | |||
| Profit Margin | (0.12) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 405.78 B | |||
| Shares Outstanding | 36.17 M | |||
| Shares Owned By Insiders | 30.90 % | |||
| Shares Owned By Institutions | 1.76 % | |||
| Price To Sales | 1.16 X | |||
| Revenue | 89.28 B | |||
| Gross Profit | 21.05 B | |||
| EBITDA | 9.93 M | |||
| Net Income | (20.23 B) | |||
| Cash And Equivalents | 27.54 B | |||
| Total Debt | 59.78 B | |||
| Cash Flow From Operations | (1.73 B) | |||
| Number Of Employees | 100 | |||
| Beta | -3.84 | |||
| Market Capitalization | 68.84 B | |||
| Total Asset | 186.94 B | |||
| Z Score | 0.6 | |||
| Net Asset | 186.94 B |
About Eone Diagnomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eone Diagnomics Genome's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eone Diagnomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eone Diagnomics Genome based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eone Diagnomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eone Diagnomics' short interest history, or implied volatility extrapolated from Eone Diagnomics options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Eone Diagnomics Genome information on this page should be used as a complementary analysis to other Eone Diagnomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Eone Stock analysis
When running Eone Diagnomics' price analysis, check to measure Eone Diagnomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eone Diagnomics is operating at the current time. Most of Eone Diagnomics' value examination focuses on studying past and present price action to predict the probability of Eone Diagnomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eone Diagnomics' price. Additionally, you may evaluate how the addition of Eone Diagnomics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |